161 related articles for article (PubMed ID: 24436031)
1. Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.
Wu W; Zhu H; Liang Y; Kong Z; Duan X; Li S; Zhao Z; Yang D; Zeng G
Int Urol Nephrol; 2014 Jul; 46(7):1345-9. PubMed ID: 24436031
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29].
Hao LX; Wang YL; Cai L; Li YY
Ai Zheng; 2007 Jun; 26(6):566-71. PubMed ID: 17562258
[TBL] [Abstract][Full Text] [Related]
4. Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.
Schlesinger M; Vilchez Larrea SC; Haikarainen T; Narwal M; Venkannagari H; Flawiá MM; Lehtiö L; Fernández Villamil SH
Parasit Vectors; 2016 Mar; 9():173. PubMed ID: 27007296
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous cell death and upregulation of poly(ADP-ribose) polymerase-1 expression in early postnatal mouse retina.
Martín-Oliva D; Ferrer-Martín RM; Santos AM; Carrasco MC; Sierra A; Marín-Teva JL; Calvente R; Navascués J; Cuadros MA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7445-54. PubMed ID: 21705688
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas.
Yang SX; Kummar S; Steinberg SM; Murgo AJ; Gutierrez M; Rubinstein L; Nguyen D; Kaur G; Chen AP; Giranda VL; Tomaszewski JE; Doroshow JH;
Cancer Biol Ther; 2009 Nov; 8(21):2004-9. PubMed ID: 19823047
[TBL] [Abstract][Full Text] [Related]
7. Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.
Barboro P; Ferrari N; Capaia M; Petretto A; Salvi S; Boccardo S; Balbi C
Int J Cancer; 2015 Oct; 137(7):1574-86. PubMed ID: 25808111
[TBL] [Abstract][Full Text] [Related]
8. Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies.
Horvath EM; Zsengellér ZK; Szabo C
Methods Mol Biol; 2017; 1608():19-26. PubMed ID: 28695500
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
10. Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue.
Salemi M; Galia A; Fraggetta F; La Corte C; Pepe P; La Vignera S; Improta G; Bosco P; Calogero AE
Eur J Histochem; 2013 Apr; 57(2):e13. PubMed ID: 23807292
[TBL] [Abstract][Full Text] [Related]
11. Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.
Perina D; Mikoč A; Ahel J; Ćetković H; Žaja R; Ahel I
DNA Repair (Amst); 2014 Nov; 23():4-16. PubMed ID: 24865146
[TBL] [Abstract][Full Text] [Related]
12. Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.
Ji J; Kinders RJ; Zhang Y; Rubinstein L; Kummar S; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2011; 6(10):e26152. PubMed ID: 22028822
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
14. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA
Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) metabolism in brain and its role in ischemia pathology.
Strosznajder RP; Czubowicz K; Jesko H; Strosznajder JB
Mol Neurobiol; 2010 Jun; 41(2-3):187-96. PubMed ID: 20411356
[TBL] [Abstract][Full Text] [Related]
16. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Zhou ZR; Zhu XD; Zhao W; Qu S; Su F; Huang ST; Ma JL; Li XY
Oncol Rep; 2013 Jun; 29(6):2498-506. PubMed ID: 23563481
[TBL] [Abstract][Full Text] [Related]
19. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
20. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
